Advertisements


High Growth Non-Invasive Cancer Test Technology: Guardant Health Vs. Exact Sciences

High Growth Non-Invasive Cancer Test Technology: Guardant Health Vs. Exact Sciences.....»»

Category: topSource: seekingalphaDec 2nd, 2019

Exact Sciences (EXAS) to Post Q1 Earnings: What"s in Store?

During Exact Sciences' (EXAS) first-quarter 2019 conference call, investor focus will be on the growth rate in the company's non-invasive screening test volume for c.....»»

Category: dealsSource: nytApr 22nd, 2019

Exact Sciences Inks Cologuard Co-Promotion Deal With Pfizer

Exact Sciences (EXAS) reaches a co-promotion agreement with Pfizer to commercialize its non-invasive screening test for colorectal cancer, Cologuard. The stock rallies fo.....»»

Category: personnelSource: nytAug 23rd, 2018

Exact Sciences A "Must-Own" Growth Stock, Goldman Sachs Says In Upgrade

Shares of EXACT Sciences Corporation (NASDAQ: EXAS), which markets the non-invasive colon cancer screener Cologuard, enjoy a premium valuation and hold further upside potential, according to Goldman Sach.....»»

Category: blogSource: benzingaFeb 26th, 2019

Exact Sciences" stock jumps after analysts question competitor"s product

Thanks to a competitor disclosing data showing its screening test isn't as efficient at detecting early-stage colon cancer, Exact Sciences Corp., the maker of the Cologuard stool-based colon cancer test, saw a leap in its stock price on Wednesday. The.....»»

Category: topSource: bizjournalsJan 23rd, 2020

Why This Colorectal Cancer Treatment Approval Is a Big Hit

One analyst sees FDA approval of its noninvasive colorectal cancer screening test tacking on another 30% to Exact Sciences stock......»»

Category: blogSource: 247wallstSep 24th, 2019

Wall Street eases from record highs as tech drags; Fed meeting eyed

U.S. stocks retreated from record highs on Monday, weighed by technology shares ahead of high profile earnings including that of Apple, which will test the impact of trade tensions on global growth, ahead of the Federal Reserve's policy-setting meeting......»»

Category: topSource: reutersJul 29th, 2019

Diagnostic company Exact Sciences to buy Genomic Health in $2.8 billion deal

Exact Sciences Corp said on Monday it will buy peer Genomic Health Inc for about $2.8 billion in cash and stock, expanding the cancer diagnostic company's testing capabilities to breast and prostate cancers......»»

Category: topSource: reutersJul 29th, 2019

Exact Sciences to buy Genomic Health for $2.8 billion

Cancer diagnostics company Exact Sciences Corp said on Monday it will buy healthcare company Genomic Health Inc for about $2.8 billion to bolster its cancer testing business......»»

Category: topSource: reutersJul 29th, 2019

Exact Sciences in advanced talks to buy Genomic Health for $2.8 billion: Bloomberg

Cancer diagnostics company Exact Sciences Corp is in advanced negotiations to buy healthcare company Genomic Health Inc for about $2.8 billion to strengthen its cancer testing, Bloomberg reported on Saturday......»»

Category: topSource: reutersJul 27th, 2019

Is Exact Sciences Corp. Still a Buy in 2018?

Shareholders in the innovative colon cancer test specialist have enjoyed huge gains over the last few years......»»

Category: topSource: foxnewsApr 8th, 2018

Exact Sciences shares surge 11% on earlier cancer screening recommendation

Exact Sciences Corp. , maker of a colon cancer test, had shares surge 11% in extre.....»»

Category: topSource: marketwatchMay 30th, 2018

Exact Sciences update on liver cancer test a positive, says Canaccord

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 6th, 2018

Exact Sciences" stock drops sharply as Madison company misses analysts" projections

Exact Sciences Corp., the maker of the Cologuard stool DNA-based colorectal cancer take-home test, saw a 78 percent increase in revenue for its recent second quarter when compared with the year-ago quarter, but still missed analysts' revenue projections......»»

Category: topSource: bizjournalsAug 2nd, 2018

Exact Sciences shares jump 11% premarket on news of Pfizer collaboration on Cologuard

Exact Sciences Corp. shares soared about 11% in premarket trade Wednesday, after the company said it will collaborate with Pfizer Inc. in co-promoting Cologuard, the first and only FDA-approved non-invasive stool DNA screening test fo.....»»

Category: topSource: marketwatchAug 22nd, 2018

Pfizer will promote Mayo-developed colon cancer test Cologuard

Global pharmaceutical company Pfizer Inc. has entered into a four-year agreement with Exact Sciences Corp. to co-promote and sell Cologuard, the noninvasive stool DNA-based colorectal cancer take-home test that was developed by Rochester, Minn.-bas.....»»

Category: topSource: bizjournalsAug 23rd, 2018

Lenexa company"s high-tech sanitation solution yields 10x growth, hiring boom

Lenexa-based Synexis' patented technology, which disinfects the air, is providing value for local restaurants and other companies......»»

Category: topSource: bizjournalsJun 23rd, 2020

BTIG starts genomic profiling test "pioneer" Guardant Health at Buy

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2020

Wisconsin has record day for Covid-19 testing, positive cases surpass 19,000

Wisconsin reached a new high for the number of Covid-19 test results in one day, with the Department of Health Services reporting Wednesday 15,968 people were tested within a 24-hour period. Of those tests, 483 were positive. Dating back to earl.....»»

Category: topSource: bizjournalsJun 3rd, 2020

Exact Sciences receives FDA EUAoapproval for COVID-19 test

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 17th, 2020

MTS Provides Update On Business And Actions Taken To Address Effects Of COVID-19 Pandemic

EDEN PRAIRIE, Minn., April 16, 2020 /PRNewswire/ -- MTS Systems Corporation (NASDAQ:MTSC), a leading global supplier of high-performance test systems, motion simulators and sensors, today announced actions it is taking to help ensure the health an.....»»

Category: earningsSource: benzingaApr 16th, 2020